Skip to main content
Erschienen in: Immunity & Ageing 1/2023

Open Access 01.12.2023 | Research

TAOK3 limits age-associated inflammation by negatively modulating macrophage differentiation and their production of TNFα

verfasst von: Alexandre Poirier, Chenyue Wu, Ana Maria Hincapie, Zuzet Martinez-Cordova, Belma Melda Abidin, Michel L. Tremblay

Erschienen in: Immunity & Ageing | Ausgabe 1/2023

Abstract

Background

Human aging is characterized by a state of chronic inflammation, termed inflammaging, for which the causes are incompletely understood. It is known, however, that macrophages play a driving role in establishing inflammaging by promoting pro-inflammatory rather than anti-inflammatory responses. Numerous genetic and environmental risk factors have been implicated with inflammaging, most of which are directly linked to pro-inflammatory mediators IL-6, IL1Ra, and TNFα. Genes involved in the signaling and production of those molecules have also been highlighted as essential contributors. TAOK3 is a serine/threonine kinase of the STE-20 kinase family that has been associated with an increased risk of developing auto-immune conditions in several genome-wide association studies (GWAS). Yet, the functional role of TAOK3 in inflammation has remained unexplored.

Results

We found that mice deficient in the serine/Threonine kinase Taok3 developed severe inflammatory disorders with age, which was more pronounced in female animals. Further analyses revealed a drastic shift from lymphoid to myeloid cells in the spleens of those aged mice. This shift was accompanied by hematopoietic progenitor cells skewing in Taok3−/− mice that favored myeloid lineage commitment. Finally, we identified that the kinase activity of the enzyme plays a vital role in limiting the establishment of proinflammatory responses in macrophages.

Conclusions

Essentially, Taok3 deficiency promotes the accumulation of monocytes in the periphery and their adoption of a pro-inflammatory phenotype. These findings illustrate the role of Taok3 in age-related inflammation and highlight the importance of genetic risk factors in this condition.
Begleitmaterial
Additional file 1: Sup. Fig. 1. Additional data pertaining to Fig. 1. a) Dot plot indicating the mean weight of male and female mice in grams (g) in different age groups (young, adult, old). b) Bar chart indicating the mean age at humane endpoint between male and female Taok3-/- mice (top). Bar chart indicating the proportion of each sex within the dead animal group. c) Pathology report for brain, lung, liver, spleen, lymph node, and colon tissues fixed in formalin and analyzed with H&E staining. d) Micrograph of H&E-stained section from WT (left) and KO (right) axillary lymph nodes at 40X (top) and 100X (bottom) magnifications. e) n/nx plots for the parameters used to calculate the UMAP in Fig. 1g. Right side table represents the representative markers used to define major splenic populations. Data representative of at least three independent litters. Each animal represents one data point (a-b). Statistical analysis: a) Two-way ANOVA with Dunnet’s multiple comparisons. (b) unpaired, bilateral T-tests. Chart error bars represent mean±SEM. Non-significant differences, ns. *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12979-023-00350-y.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Age-related inflammation, or inflammaging, is a common phenomenon characterized by increased levels of pro-inflammatory factors in the blood [1]. Contrary to acute inflammation and its role in immunity, chronic inflammation is highly detrimental to general health. It is a central risk factor for numerous age-related morbidities such as cardiovascular disease, diabetes, cancer, and kidney disease [1]. Fundamentally, chronic inflammation is hallmarked by a complex disbalance between pro-and anti-inflammatory responses that, in the case of inflammaging, are predominantly controlled by macrophages [2, 3]. Besides their role in apoptotic cell clearance and innate immunity, macrophages are the most potent producers of TNFα, a pro-inflammatory cytokine involved in numerous inflammatory and auto-immune disorders [4]. Systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) are such diseases and have been found to affect females disproportionally [5]. Sex-based associations remain undetermined in inflammaging, but emerging reports suggest such differences [5, 6]. Thus far, the most important genetic factors for inflammaging are polymorphism in IL-6 [7], its receptor IL-6R [8], and IL-1RN (IL1Ra antagonist gene) [9].
Thousand-and-one (TAO) kinases belong to a subfamily of Ste20-like proteins that can act as MAP4Ks to phosphorylate MAP3Ks [1013]. The TAO kinase family members have been shown to share kinase domain resemblance and substrate specificity with conventional MAP4K enzymes [14, 15]. The function of those enzymes is involved in immune and inflammatory disorders such as RA and SLE [16]. To our knowledge, it remains unknown whether TAOKs are involved in inflammatory disorders and, more broadly, if STE20-kinases are implicated with inflammaging. Among the three members of TAOs kinases, TAOK3 uniquely shows increased expression in the hematopoietic compartment, especially in macrophages [17, 18]. TAOK3 has already been found to be essential for various immune cell types and processes, such as T cell activity [19], marginal zone B cell formation [20], type 2 conventional dendritic cell homeostasis [21], and asthma [22]. Its function in macrophages and, more importantly, in chronic inflammation is unknown. Herein, we employ genetic and pharmacological tools to investigate the role of TAOK3 in the secretion of pro-inflammatory mediators. We found that aged knockout mice, especially females, had enlarged spleens. We associated splenomegaly with increased myeloid cell numbers and the commitment of hematopoietic progenitor cells toward myelopoiesis. Finally, the kinase activity of Taok3 limits the differentiation of macrophages and their polarization towards pro-inflammatory responses.

Results

Taok3 deficient mice develop severe skin ulcerations with age

We studied the possible establishment of age-related inflammatory disorders using a cohort of Taok3+/+ (WT), Taok3± (HET), and Taok3−/− (KO) littermates. Mice were followed-up until they reached the age of 80 weeks or 1.5 years. We first identified that knockout and heterozygous animals developed severe ulcerative dermatitis (UD), which necessitated euthanasia per-humane endpoint (Fig. 1a, b, c). The median survival for Taok3+/+, Taok3±, and Taok3−/− animals was 79.5, 69.5, and 59 weeks respectively (Fig. 1a). In the vast majority of cases, UD lesions for both Taok3± and Taok3−/− animals was found around the neck and shoulder area, suggesting that lesions occur after scratching (Fig. 1b). Skin ulcerations are not uncommon in mice with C57/B6 background [23, 24].

Splenic enlargement in Taok3 deficient mice is associated with increased myeloid cell frequency

Idiopathic UD is linked to behavioral, commensal, environmental, and inflammatory factors alike [24]. We graded the lesions based on previous reports [24] (Fig. 1c). We thus performed full-body necropsies on mice that did not have UD to pinpoint a plausible cause for the lesions further. Given the highly heterogeneous nature of the UD lesions within each group, we cannot rule out that other factors, such as aggressivity, stress and scratching intensity, are also plausible contributors to these lesions. All further analyses were also conducted in unaffected animals. We found that Taok3−/− mice had enlarged spleens, which was more pronounced in female mice (Fig. 1d, e). We also observed loss of follicular architecture and cellular proliferation in the white pulp of the spleen (Fig. 1f). This meant that the splenomegaly was most likely driven by the accumulation of immune cells within the spleen. To investigate the immune populations responsible for this enlargement, we performed flow cytometric analyses on splenocytes of 12–15-week-old (Young) and 60–70-week-old (Old) non-lesioned animals. We used a 19-color flow cytometry panel to perform algorithmic population clustering using Uniform Manifold Approximation and Projection (UMAP) [25] (Fig. 1g). We found that both young and old Taok3 deficient mice had an increase in myeloid populations (Monocytes, neutrophils) (Fig. 1h, i). In older mice, this increase was also accompanied by a decrease in the frequency of lymphocyte populations (B cells, CD4 + T cells) (Fig. 1h, i). Differences between the genotypes were the most drastic in older mice, as demonstrated by the distance in the average UMAP1 parameter (Fig. 1i). Indeed, percentages of splenic myeloid cells were 9.3% and 19% in young wild-type and young knockout mice, respectively (Fig. 1i). On the other hand, it was 15% and 29% in older mice (Fig. 1i). These data suggest that Taok3 deficient mice accumulate myeloid cells in their spleens. This accumulation was found to be more drastic in older females.
Since we observed a decrease in lymphoid cells in favor of myeloid populations in the spleens, we wondered whether Taok3 deletion affected myelopoiesis in the bone marrow. To investigate this, we employed flow cytometric analysis of hematopoietic progenitor cells in the bone marrow of young and old mice. We found that the frequency and numbers of progenitor LSK + (Lineage-, Sca-1 + , C-kit +) cells were increased in both young and old knockout animals (Fig. 2a, b). We next measured the proportions of long-term HSCs (LT-HSCs; LSK + CD150 + CD48 +), short-term HSCs (ST-HSCs; LSK + CD150 + CD48 +), and multipotent progenitors (MPPs; LSK + CD150-CD48 +). In both age groups, a significant increase in the frequency and numbers of MPPs was observed in KO versus WT animals (Number of MPPs (× 103): Young-WT: 24.4; Young-KO 58 (1-fold increase), Old-WT: 15.5; Old-KO: 72.3 (4.8-fold)) (Fig. 2c, d). It is well known that aging favors myeloid lineage differentiation rather than lymphoid lineage commitment in hematopoietic stem cells (HSCs) [26, 27]. This skewing can also be observed within MPP progenitors. Indeed, MPP3 progenitors are polarized toward myeloid lineages, whereas MPP4s are polarized toward lymphoid lineages [28, 29]. We found no differences between the proportions of MPP3 and MPP4 cells in young mice (Fig. 2e, f). As expected, there was an increase in MPP3 frequency in aged mice. This increase was more dramatic in knockout animals, which implies further commitment towards myelopoiesis rather than lymphopoiesis (Fig. 2f). The B-cell to myeloid (CD11b +) ratio was found to be decreased in the bone marrow and peripheral blood of Taok3 deficient mice (Fig. 2h). The skewing towards myelopoiesis could at least partly explain why these mice had more myeloid cells in their spleens, bone marrow, and peripheral blood. Altogether, those results indicate that Taok3 limits age-related myelopoiesis commitment.

Taok3 deletion increases pro-inflammatory cytokine levels in the blood

It remained unknown, however, whether the function of those myeloid cells was increased and how they could negatively impact survival and inflammation. We measured the levels of pro-inflammatory factors in 12–15 weeks old (Young) and 60–70 old (Old) mice. To do so, we performed cytokine multiplexing in the serum of those animals at a steady state (Fig. 3a). Out of the 44 markers tested, we found that CXCL9 (2.1-fold), G-CSF (2.1-fold), IL-6 (12.9-fold) and IL-5 (1.87-fold) levels were elevated in young knockout versus young wild-type animals (Fig. 3a). We also detected a trend towards increased levels of IL-1β in young KO animals (although not statistically significant). The increase of IL-1β and IL-6 is consistent with a systemic inflammatory trigger preceding the phenotypes described earlier (UD and splenomegaly). In older mice, we found elevated CXCL9 (1.9-fold), TNFα (1.7-fold), and MIP-3β (3.93-fold). There was also a trend in both young and old KOs towards increased IL-4 levels, which goes in line with that UD lesions are a result of increased Type I hypersensitivity. Conversely, we found decreased levels of IL-1α (-70%) in older Taok3−/− mice (Fig. 3a). We next stratified the levels of those cytokines/chemokines by sex to determine whether those factors could be implicated in the sex-dependent observation shown before. As expected, only female knockout mice had a significant increase in their CXCL9 and TNFα levels compared to female wild-type (Fig. 3b). We did not detect significant sex-dependent associations in the other differentially secreted factors (IL-6, IL-5, MIP-3β, and IL-1α). These observations indicate that Taok3 negatively modulates the production of pro-inflammatory cytokines and that sex-dependent factors modulate this function. These pieces of evidence point to Taok3−/− mice having an accentuation of normal-age-related inflammation, rather than specific pathologies.

Increased monocyte trafficking in Taok3−/− mice with acute peritonitis

In addition to its role in myeloid cell differentiation and function, CXCL9 is a major factor in the leukocyte trafficking and migration [30, 31]. We, therefore, investigated whether Taok3 deficient mice had increased capacity for myeloid cell transmigration in vivo. To do so, we induced acute peritonitis with intraperitoneal (i.p) injections of 3.4% thioglycollate. Under steady-state conditions, the peritoneal cavity is mainly populated by resident large peritoneal macrophages (LPMs) (CD11b + , F4/80 +) and B cells. Inflammation induces the transmigration of monocytes (CD11b + , F4/80lo, MHC II +) to the peritoneal cavity. These monocytes then continuously differentiate into small-peritoneal macrophages (SPMs) (CD11b + , F4/80lo, MHC II +), which secrete pro-inflammatory mediators, such as TNFα [32]. We did not observe any differences in the proportion of macrophages and B cells under steady-state conditions (Fig. 3c). However, the induction of acute peritonitis in Taok3 deficient mice significantly increased the proportion of CD11b + cells compared to wild type (Fig. 3c). Further analysis revealed that the vast majority of cells (89%) were not resident LPMs, but either SPMs (17%) or monocytes (72%) (Fig. 3d). For comparison, wild-type animals had 6% of SPMs, 5.8% of monocytes and 88% of resident LPMs in their peritoneal cavity (Fig. 3d). It implies that most of the cells that populated the peritoneal cavity of Taok3−/− mice after the induction of peritonitis migrated from the periphery. This result suggests that under normal circumstances, Taok3 limits the recruitment of monocytes to sites of inflammation.

Taok3 negatively modulates the differentiation of bone marrow-derived macrophages and their secretion of pro-inflammatory cytokines

We next wondered whether Taok3 deficiency directly affected macrophages' function and pro-inflammatory cytokine production. We used M-CSF at 30 ng/mL for 6 days to differentiate (CD11b + , F4/80 +) macrophages from bone marrow cells (Fig. 4a). To unravel the role of this kinase in macrophage function, we then polarized those bone marrow-derived macrophages (BMDMs) to unpolarized M0, polarized M1, and M2 macrophages. Activation of macrophages with LPS and IFN-γ (100 ng/mL and 20 ng/mL respectively for 24 h) yields “classically” activated or M1 macrophages that produce pro-inflammatory cytokines such as IL-6 and TNFα [33]. Conversely, adding IL-4 (20 ng/mL for 24 h) will promote the polarization of "alternative" or M2 macrophages that have essential anti-inflammatory functions [33]. M0 macrophages correspond to unpolarized BMDMs that received M-CSF instead of the aforementioned polarization cocktails. We observed that Taok3-deficient M1 polarized BMDMs had increased expression of F4/80, IL-6, and inducible nitric oxide synthase (iNOS) (Fig. 4b). These cells also had decreased expression of IL-4 receptor alpha chain (IL-4Rα), a molecule responsible for mediating anti-inflammatory signals. These results, combined with the fact that M2 polarized macrophages had lower IL-10 and higher iNOS expression, indicate that Taok3 deficiency favors pro-inflammatory rather than anti-inflammatory responses in polarized macrophages originating from bone-marrow progenitors. M0 and M1 macrophages had increased TNFα production, as measured in the supernatants of those cultures by ELISA (Fig. 4c). We also observed significant changes in the expression of F4/80 in M0 BMDMs, which might imply that Taok3 alters not only the polarization but also the differentiation of macrophages from progenitor cells. We next wondered whether the absence of Taok3 could modulate the differentiation of other myeloid cell types, such as dendritic cells. We used GM-CSF at 20 ng/mL to induce the differentiation of bone marrow-derived dendritic cells (BMDCs) over a 6-day period. These BMDCs are characterized by high levels of CD11c at their surface. The purpose of this experiment was to measure whether Taok3 deletion also impacted Dendritic cell differentiation. In these experiments, we noticed an increase in the frequency of both BMDCs (GM-CSF) and BMDMs (M-CSF) populations after six days of differentiation (Fig. 4d). It is therefore possible that under normal conditions, Taok3 limits the effects of GM-CSF and M-CSF in myeloid cell differentiation. To further characterize these bone marrow-derived cells, we quantified the expression of receptors and transcription factors. In BMDCs, only the CD86 co-receptor was found to be significantly decreased in KO vs. WT cells (Fig. 4e). BMDMs, on their part, had reduced levels of TLR-4, the pattern recognition receptor that binds LPS, interferon response factor 4 (IRF4) and PD-L1. Conversely, Knockout BMDMs had higher levels of TNFR1 and CD11b (Fig. 4e). The decrease in IRF4 aligns with the hypothesis that Taok3 deficiency limits alternative polarization response in macrophages, given that IRF4 is crucial for shaping the phenotype of M2 macrophages [34].
Given that bone marrow progenitor cells were shown to be skewed towards myelopoiesis, it remained possible that alternative transcriptional programs were already found in precursors of BMDMs before differentiation with M-CSF. We thus used a small molecule inhibitor of TAO- family kinases, compound-43 [35], to validate our previous findings and to make two demonstrations: 1. That the catalytic/kinase activity of Taok3 is important in controlling TNFα production and M1 pro-inflammatory responses and 2. that those changes are intrinsic to differentiating macrophages and not a result of differential gene expression in progenitors. Using 5 µM of compound-43, we tested whether the phenotype relied on inhibition during the differentiation phase (Day 0–6) or the polarization phase (Day 6–7). We used four different treatment conditions: DMSO → DMSO (D → D), DMSO → TAOKi (D → T), TAOKi → DMSO (T → D), and TAOKi → TAOKi (T → T) that represent the phase at which the drug/vehicle was added (Differentiation → Polarization). As expected, only the BMDMs treated during their differentiation phase (TAOKi → DMSO) had an increased frequency of BMDMs compared to the DMSO → DMSO control group (Fig. 4f). We next polarized those BMDMs to M1 macrophages using the same method as described previously to validate previous findings in a macrophage-intrinsic model. We observed that administration of TAOK inhibitor, regardless of condition, consistently increased CD11b expression (Fig. 4g). This increase was also accompanied by an increase in F4/80 in TAOKi → DMSO M0 and M1 macrophages.
Most importantly, inhibition of Taoks resulted in a significant increase in iNOS expression, which was more pronounced in T → D and T → T conditions (Fig. 4g). iNOS is a critical enzyme in the macrophage inflammatory response and is responsible for inducing bacterial killing via nitric oxide (NO) synthesis [33, 36]. We also quantified TNFα levels in the supernatants of those conditions using ELISA. We found that only M1 macrophages that had received TAOKi during their differentiation phase (T → D and T → T) had increased concentrations of TNFα (Fig. 4h). This result not only validates the previous findings in a cell-intrinsic manner but also provides evidence for the importance of the kinase activity of Taok3 during the differentiation of macrophages. Altogether, these findings demonstrate that Taok3 negatively modulates the differentiation of bone marrow-derived macrophages and their secretion of pro-inflammatory cytokines IL-6 and TNFα. In addition to this function, in vitro and in vivo results suggest that Taok3 has a role in limiting sex and age-related inflammation through its role in leukocytes.

Discussion

With the increase in life expectancy worldwide, the number of aged individuals is set to rise to historic highs in the following decades. With increasing age comes inflammaging, an incompletely understood condition that increases the risk of chronic diseases. Here, we uncovered that an unexpected gene, TAOK3, plays a role in limiting inflammaging by negatively modulating the polarization of macrophages towards pro-inflammatory responses. We identified that the kinase activity of the enzyme is necessary for limiting macrophage differentiation in-vitro. Our study supports the mounting evidence for the implication of innate immune cells and their receptors in chronic inflammation [37]. Other essential macrophage functions we did not cover include efferocytosis and debris clearance within the organism. The importance of those functions with inflammaging has already been demonstrated [2, 38]. Our findings support that genetic factors can induce susceptibility to pro-inflammatory cytokine and chemokine production in a sex-dependent manner. Such associations are important for understanding other diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), given that those diseases disproportionately affect women. These diseases, along with inflammatory skin conditions, strongly implicate the pro-inflammatory functions of TNF-α [39]. Our findings involving TAOK3, TNF-α, and ulcerative dermatitis in mice, further support this implication. TAOK3 single nucleotide polymorphisms (SNPs) have also been linked with an increased risk of SLE [40]. The rs428073 SNP encodes a C-T missense variant causing the S47N substitution. The functional role of this mutation remains unknown, but the variant is near the predicted ATP binding site. Thus, it may interfere with the catalytic activity of the kinase. Our study demonstrates that the Ser/Thr kinase activity of TAOK3 is important in limiting pro-inflammatory responses in macrophages. Several groups have shown that inhibiting the enzyme induces anti-cancer responses [35, 41, 42]. A demonstrated relationship between NF-κB mediated signaling and TAOK3 could also imply the presence of inflammatory responses in cancer cells [43]. TAOK3 has also been implicated in skeletal mineralization by modulating the differentiation of osteoblasts [44]. This brings essential implications, given the established link between age-related inflammation and bone disorders, such as osteoporosis [45]. TAOK3, and possibly other STE-20 kinases, finds itself at the center of an association between inflammation, sex-specific associations, and innate immunity. We are limited in our interpretation of our data, given that we do not possess a tissue-specific knockout model. Such a model would be paramount in dissecting other macrophage-specific functions, such as efferocytosis and phagocytosis. We are also limited in the statistical power of our study. We also uncovered an unexpected role for TAOK3 in hematopoiesis. It remains unclear, however, at which precise stage does Taok3 participates in hematopoiesis. The cell-autonomous effects of the kinase in this setting also remain unknown. Many different molecular mechanisms could explain the phenotypes observed here. TAOK3 has already been linked to Notch signaling in other immune cell types [20, 21]. However, it seems unlikely that this mode of action is central here, given the reported positive role of TAOK3 in Notch signaling and the importance of Notch signaling in the M1 polarization [46, 47]. Overall, our findings align with previous reports stating that other STE-20 enzymes negatively modulate macrophage function and pro-inflammatory responses [16, 48, 49]. Thus, like the other STE-20 kinases, TAOK3 could be involved in innate receptor signaling, such as TLR receptors, through interaction with TRAF proteins [16]. TAOK3 has been previously demonstrated to interact with TRAF2, although it was not in the context of TLR signaling [50]. TAOK1, which is 73.56% identical in amino acid sequence to TAOK3, was shown to interact with TRAF6 during IL-17-mediated inflammation [48]. These reports, combined with recent evidence showing that some TLRs are involved in sex-dependent inflammatory and auto-immune disorders, provide further directions for studying the mechanism by which TAO kinases operate [37, 51, 52].

Methods

Mice

Whole-body Taok3 KO mice were purchased from Jackson Laboratories MMRRC stock #43,790. These mice were generated by the KOMP team using a CRISPR-generated KO mutant of the Taok3 kinase by deleting exon 6, leading to a frameshift mutation causing an early stop codon [53]. This frameshift nullifies protein expression but not mRNA transcription. Taok3−/− mice were bred with background-compatible C57/Bl6 mating partners. Control animals for Taok3−/− mice were Taok3+/+ littermates from the heterozygous breedings mentioned above. Animals were housed and bred in specific-pathogen-free facilities at the Comparative Medicine and Animal Resources Centre (CMARC) at McGill University in accordance with the Canadian Council on Animal Care Guidelines.

Histology

Tissues were fixed in 10% Buffered formalin. From fixed tissue, representative sections were trimmed and processed for paraffin embedding. Paraffin blocks are cut at a width of approximately 4 µm onto glass slides and stained with hematoxylin and eosin.

Flow cytometry

Staining and washing were performed in round bottom polystyrene 5 mL tubes (Falcon, 14–959-6). Unless otherwise stated, intracellular staining was performed with the BD biosciences Fixation/Permeabilization solution (BD Biosciences, 554,714) according to the manufacturer’s protocol. Beferdin A (BD Biosciences, 555,029) solution was used as the protein transport inhibitor during intracellular stainings. A 1:1000 dilution was incubated directly in cell culture plates for 4 h before stainings. Data were acquired using the Cytek Aurora (19-color panel) and the BD 5-laser LSR FORTESSA. Data were analyzed using FlowJo. V10 software.
Antibodies: Bone marrow HSCs: Anti-CD3-Biotin(Biolegend,1:400),TER119-Biotin(Biolegend,1:400),CD11b-Biotin (Biolegend,1:400), CD45R-Biotin(Biolegend,1:400), GR-1-Biotin (Biolegend,1:400), C-kit-APC (Biolegend,1:400), Sca-1-PECY7 (Biolegend,1:400), CD48-BV605 (Biolegend,1:300), CD150-BV450 (Biolegend,1:300), FLT3-PE (Biolegend,1:300), CD34-FITC (Biolegend,1:300), D16/32-APCCY7 (Biolegend, 1:300), IL7RA-BV785 (Biolegend,1:300). Spleens: CD19-AF647 (Biolegend, 1:1600), B220-AF700 (Biolegend, 1:800), IgM -BV605 (Biolegend, 1:200), IgD-PerCPCy5.5 (Biolegend, 1:400), CD3-APC/Fire810 (Biolegend, 1:150), CD4-PE/Dazzle 594 (Biolegend, 1:800), CD8-Pacific Blue (Biolegend, 1:600), CD44-BV421 (Biolegend, 1:400), CD62L-BV786 (BD, 1:1200), NK1.1-FITC(Biolegend, 1:300), TCRb-APC (Biolegend, 1:200), Ter119-BV650(Biolegend, 1:400), CD71-PE(Biolegend, 1:800), Ly6G-PE/Cy7 (Biolegend, 1:400), Ly6C-APC/Cy7(Biolegend, 1:400), CD11b-SparkYG593 (Biolegend, 1:800), CD11c-BV510(Biolegend, 1:150), F4/80-PE/Cy5 (Biolegend, 1:600), MHCII Spark Blue 550(Biolegend, 1:800), F4/80-PECY5 (Biolegend, 1:600), CD11c -PE (Biolegend, 1:600), GR1 (bv650) biotin (Biolegend, 1:500), CD126-PECY7(Biolegend, 1:400), CD86 (BV786)(Biolegend, 1:300), PD-L1-APC(Biolegend,1:1:200),CD44-PECY7 (Biolegend, 1:1:300),MHC1-PERCPCY5.5(Biolegend,1:1:200), CCR7-BV421 (Biolegend, 1:1:300),CD11b-FITC (Biolegend, 1:500), IL4-Rα-PECY7 (Biolegend, 1:300),IL-6-PE(Biolegend, 1:100), IRF4-BV421 (Biolegend, 1:100), iNOS-APC (Biolegend, 1:300).

Generation of BMDMs and BMDCs

Bone marrow from both femurs and tibiae was harvested in Dulbecco's High Glucose Modified Eagles Medium (DMEM) (Cytiva, SH30022FS) supplemented with 10% heat-inactivated FBS (Life technologies, 12,483,020). Marrows were filtered through a 70 μm Nylon cell strainer (Corning, 07–201-431) to remove solid fragments. The filtrate was centrifuged at 300 × g for 5 min at 4 °C. Cells were subsequently seeded in 2 ml DMEM supplemented with 10% hi-FBS, 1% non-essential amino acids (Gibco, 11,140,050), 1 mM sodium pyruvate (Gibco, 11,360,070), 2 mM L-Glutamine (Glutamax) (Gibco, 35,050,061), 100U/ml penicillin–streptomycin (Gibco, 15,140,122) in 6-well plates at a density of 1 × 105 cells/mL. Recombinant murine M-CSF (Preprotech, 315–02) was added directly to the wells on days 0, 3, and 6 at a final concentration of 30 ng/mL. The same method was employed to generate BMDCs, but with 20 ng/mL of recombinant murine GM-CSF (Preprotech, 315–03) and 5 ng/mL of recombinant murine IL-4 (Preprotech, 214–14). BMDCs were in their immature “unactivated” state during that study. Cells were harvested by gentle scraping and washing with PBS. Washed cells were then used for downstream applications.
For the polarization, 100 ng/mL of LPS (LPS from E. coli O111:B4, InVivogen, tlrl-3pelps) and 20 ng/mL of recombinant murine IFNγ (Preprotech, 315–05) were used to induce M1 macrophages for 24 h. For M2 macrophages, 20 ng/mL of recombinant murine IL-4 (Preprotech, 214–14) was added to the culture wells for 24 h.
The TAO kinases inhibitor, compound 43, was diluted in DMSO (water insoluble) and purchased from Cayman chemicals (Ref: 25632).

Enzyme-linked immunosorbent assays (ELISA) and cytokine/chemokine multiplexing

Supernatant from BMDM cultures was collected on day 7 ( 24 h post-polarization) and kept at -80C until downstream analysis. Mouse IL-6 (Biolegend, 431,301) and TNFα (Biolegend, 430,904) were used as per the manufacturer's protocol.
For cytokine multiplexing, serum was collected through cardiac puncture using 1 mL syringes and 25G × 1 needles (BD biosciences). Blood was transferred to S-Monovette® Serum Gel, 1.1 mL collection vessels (Sarstedt, 06.1667.001) and was left to cloth for 30 min at room temperature. Vessels were then centrifuged at 2000 × g for 10 min. Supernatants (serum) were collected and stored in new tubes at -80C until downstream analysis. For cytokine multiplexing, serum was diluted onefold before being sent to EVE Technologies, Calgary, Alberta, Canada, for cytokine multiplexing with a Bio-Plex 200.

Statistical analysis

GraphPad Prism software v9.0a (GraphPad Software) was used to prepare graphs and perform statistical analysis. We used a two-tailed student T-test for pairwise comparisons to determine statistical differences between distributions. ns, not significant, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.000.

Acknowledgements

We thank all members of the Tremblay laboratory for their thorough overview of the manuscript. We thank the Flow-cytometry and CMARC core facilities of the Life Science complex of McGill University. We highlight the work of Rosalie Michaud, Audrée Laliberté, and Catherine Gagné for their care of the mice. For the full-body Taok3-/- mice generation, we thank the JAX KOMP2 team and the NIH common fund U42OD011185.

Declarations

All animal procedures, experiments, and care were approved by the Animal Ethics Review of McGill University and in concordance with the Canadian Council on Animal Care Guidelines.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anhänge

Supplementary Information

Additional file 1: Sup. Fig. 1. Additional data pertaining to Fig. 1. a) Dot plot indicating the mean weight of male and female mice in grams (g) in different age groups (young, adult, old). b) Bar chart indicating the mean age at humane endpoint between male and female Taok3-/- mice (top). Bar chart indicating the proportion of each sex within the dead animal group. c) Pathology report for brain, lung, liver, spleen, lymph node, and colon tissues fixed in formalin and analyzed with H&E staining. d) Micrograph of H&E-stained section from WT (left) and KO (right) axillary lymph nodes at 40X (top) and 100X (bottom) magnifications. e) n/nx plots for the parameters used to calculate the UMAP in Fig. 1g. Right side table represents the representative markers used to define major splenic populations. Data representative of at least three independent litters. Each animal represents one data point (a-b). Statistical analysis: a) Two-way ANOVA with Dunnet’s multiple comparisons. (b) unpaired, bilateral T-tests. Chart error bars represent mean±SEM. Non-significant differences, ns. *p≤0.05, **p≤0.01, ***p≤0.001, ****p≤0.0001.
Literatur
1.
2.
Zurück zum Zitat Franceschi C, Garagnani P, Vitale G, Capri M, Salvioli S. Inflammaging and ‘Garb-aging.’ Trends Endocrinol Metab. 2017;28(3):199–212.PubMedCrossRef Franceschi C, Garagnani P, Vitale G, Capri M, Salvioli S. Inflammaging and ‘Garb-aging.’ Trends Endocrinol Metab. 2017;28(3):199–212.PubMedCrossRef
3.
Zurück zum Zitat Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576–90.PubMedCrossRef Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576–90.PubMedCrossRef
4.
Zurück zum Zitat Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech. 2000;50(3):184–95.PubMedCrossRef Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech. 2000;50(3):184–95.PubMedCrossRef
5.
Zurück zum Zitat Milan-Mattos JC, Anibal FF, Perseguini NM, Minatel V, Rehder-Santos P, Castro CA, et al. Effects of natural aging and gender on pro-inflammatory markers. Braz J Med Biol Res. 2019;52(9):e8392.PubMedPubMedCentralCrossRef Milan-Mattos JC, Anibal FF, Perseguini NM, Minatel V, Rehder-Santos P, Castro CA, et al. Effects of natural aging and gender on pro-inflammatory markers. Braz J Med Biol Res. 2019;52(9):e8392.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Galbarczyk A, Klimek M, Blukacz M, Nenko I, Jabłońska M, Jasienska G. Inflammaging: Blame the sons. Relationships between the number of sons and the level of inflammatory mediators among post-reproductive women. Am J Phys Anthropol. 2021;175(3):656–64.PubMedCrossRef Galbarczyk A, Klimek M, Blukacz M, Nenko I, Jabłońska M, Jasienska G. Inflammaging: Blame the sons. Relationships between the number of sons and the level of inflammatory mediators among post-reproductive women. Am J Phys Anthropol. 2021;175(3):656–64.PubMedCrossRef
7.
8.
Zurück zum Zitat Swerdlow DI, Holmes MV, Kuchenbaecker KB, Engmann JE, Shah T, Sofat R, et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012;379(9822):1214–24.PubMedCrossRef Swerdlow DI, Holmes MV, Kuchenbaecker KB, Engmann JE, Shah T, Sofat R, et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet. 2012;379(9822):1214–24.PubMedCrossRef
9.
Zurück zum Zitat Rafiq S, Stevens K, Hurst AJ, Murray A, Henley W, Weedon MN, et al. Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun. 2007;8(4):344–51.PubMedCrossRef Rafiq S, Stevens K, Hurst AJ, Murray A, Henley W, Weedon MN, et al. Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels. Genes Immun. 2007;8(4):344–51.PubMedCrossRef
11.
12.
Zurück zum Zitat Kapfhamer D, King I, Zou ME, Lim JP, Heberlein U, Wolf FW. JNK pathway activation is controlled by Tao/TAOK3 to modulate ethanol sensitivity. PLoS one. 2012;7(12):e50594.PubMedPubMedCentralCrossRef Kapfhamer D, King I, Zou ME, Lim JP, Heberlein U, Wolf FW. JNK pathway activation is controlled by Tao/TAOK3 to modulate ethanol sensitivity. PLoS one. 2012;7(12):e50594.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Chen Z, Raman M, Chen L, Lee SF, Gilman AG, Cobb MH. TAO (Thousand-and-one Amino Acid) Protein Kinases Mediate Signaling from Carbachol to p38 Mitogen-activated Protein Kinase and Ternary Complex Factors. J Biol Chem. 2003;278(25):22278–83.PubMedCrossRef Chen Z, Raman M, Chen L, Lee SF, Gilman AG, Cobb MH. TAO (Thousand-and-one Amino Acid) Protein Kinases Mediate Signaling from Carbachol to p38 Mitogen-activated Protein Kinase and Ternary Complex Factors. J Biol Chem. 2003;278(25):22278–83.PubMedCrossRef
14.
Zurück zum Zitat Johnson JL, Yaron TM, Huntsman EM, et al. An atlas of substrate specificities for the human serine/threonine kinome. Nature. 2023;613:759–66. Johnson JL, Yaron TM, Huntsman EM, et al. An atlas of substrate specificities for the human serine/threonine kinome. Nature. 2023;613:759–66.
15.
Zurück zum Zitat Miller CJ, Lou HJ, Simpson C, van de Kooij B, Ha BH, Fisher OS, et al. Comprehensive profiling of the STE20 kinase family defines features essential for selective substrate targeting and signaling output. PLoS Biol. 2019;17(3):e2006540.PubMedPubMedCentralCrossRef Miller CJ, Lou HJ, Simpson C, van de Kooij B, Ha BH, Fisher OS, et al. Comprehensive profiling of the STE20 kinase family defines features essential for selective substrate targeting and signaling output. PLoS Biol. 2019;17(3):e2006540.PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Chuang HC, Wang X, Tan TH. MAP4K family Kinases in immunity and inflammation. Adv Immunol. 2016;129:277–314.PubMedCrossRef Chuang HC, Wang X, Tan TH. MAP4K family Kinases in immunity and inflammation. Adv Immunol. 2016;129:277–314.PubMedCrossRef
17.
Zurück zum Zitat Yustein JT, Xia L, Kahlenburg JM, Robinson D, Templeton D, Kung H-J. Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38. Oncogene. 2003;22(40):6129–41.PubMedCrossRef Yustein JT, Xia L, Kahlenburg JM, Robinson D, Templeton D, Kung H-J. Comparative studies of a new subfamily of human Ste20-like kinases: homodimerization, subcellular localization, and selective activation of MKK3 and p38. Oncogene. 2003;22(40):6129–41.PubMedCrossRef
18.
Zurück zum Zitat Uhlen M, Karlsson MJ, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366(6472):eaax9198.PubMedCrossRef Uhlen M, Karlsson MJ, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366(6472):eaax9198.PubMedCrossRef
19.
Zurück zum Zitat Ormonde JVS, Li Z, Stegen C, Madrenas J. TAOK3 Regulates canonical TCR signaling by preventing early SHP-1–mediated inactivation of LCK. J Immunol. 2018;201(11):3431–42.PubMedCrossRef Ormonde JVS, Li Z, Stegen C, Madrenas J. TAOK3 Regulates canonical TCR signaling by preventing early SHP-1–mediated inactivation of LCK. J Immunol. 2018;201(11):3431–42.PubMedCrossRef
20.
Zurück zum Zitat Hammad H, Vanderkerken M, Pouliot P, Deswarte K, Toussaint W, Vergote K, et al. Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10. Nat Immunol. 2017;18(3):313–20.PubMedCrossRef Hammad H, Vanderkerken M, Pouliot P, Deswarte K, Toussaint W, Vergote K, et al. Transitional B cells commit to marginal zone B cell fate by Taok3-mediated surface expression of ADAM10. Nat Immunol. 2017;18(3):313–20.PubMedCrossRef
21.
Zurück zum Zitat Vanderkerken M, Maes B, Vandersarren L, Toussaint W, Deswarte K, Vanheerswynghels M, et al. TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells. Proc Natl Acad Sci. 2020;117(49):31331–42.PubMedPubMedCentralCrossRef Vanderkerken M, Maes B, Vandersarren L, Toussaint W, Deswarte K, Vanheerswynghels M, et al. TAO-kinase 3 governs the terminal differentiation of NOTCH2-dependent splenic conventional dendritic cells. Proc Natl Acad Sci. 2020;117(49):31331–42.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Maes B, Smole U, Vanderkerken M, Deswarte K, Van Moorleghem J, Vergote K, et al. The STE20 kinase TAOK3 controls the development house dust mite–induced asthma in mice. J Allergy Clin Immunol. 2022;149(4):1413–27.e2. Maes B, Smole U, Vanderkerken M, Deswarte K, Van Moorleghem J, Vergote K, et al. The STE20 kinase TAOK3 controls the development house dust mite–induced asthma in mice. J Allergy Clin Immunol. 2022;149(4):1413–27.e2.
23.
Zurück zum Zitat Williams LK, Csaki LS, Cantor RM, Reue K, Lawson GW. Ulcerative dermatitis in C57BL/6 mice exhibits an oxidative stress response consistent with normal wound healing. Comp Med. 2012;62(3):166–71.PubMedPubMedCentral Williams LK, Csaki LS, Cantor RM, Reue K, Lawson GW. Ulcerative dermatitis in C57BL/6 mice exhibits an oxidative stress response consistent with normal wound healing. Comp Med. 2012;62(3):166–71.PubMedPubMedCentral
24.
Zurück zum Zitat Hampton AL, Hish GA, Aslam MN, Rothman ED, Bergin IL, Patterson KA, et al. Progression of ulcerative dermatitis lesions in C57BL/6Crl mice and the development of a scoring system for dermatitis lesions. J Am Assoc Lab Anim Sci. 2012;51(5):586–93.PubMedPubMedCentral Hampton AL, Hish GA, Aslam MN, Rothman ED, Bergin IL, Patterson KA, et al. Progression of ulcerative dermatitis lesions in C57BL/6Crl mice and the development of a scoring system for dermatitis lesions. J Am Assoc Lab Anim Sci. 2012;51(5):586–93.PubMedPubMedCentral
25.
Zurück zum Zitat McInnes L, Healy J, Melville J. UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction (arxiv.org). 2018; arXiv:1802.03426. McInnes L, Healy J, Melville J. UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction (arxiv.org). 2018; arXiv:1802.03426.
26.
Zurück zum Zitat Florian MC, Klose M, Sacma M, Jablanovic J, Knudson L, Nattamai KJ, et al. Aging alters the epigenetic asymmetry of HSC division. PLoS Biol. 2018;16(9):e2003389.PubMedPubMedCentralCrossRef Florian MC, Klose M, Sacma M, Jablanovic J, Knudson L, Nattamai KJ, et al. Aging alters the epigenetic asymmetry of HSC division. PLoS Biol. 2018;16(9):e2003389.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, Rossi DJ, et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A. 2011;108(50):20012–7.PubMedPubMedCentralCrossRef Pang WW, Price EA, Sahoo D, Beerman I, Maloney WJ, Rossi DJ, et al. Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A. 2011;108(50):20012–7.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Pietras EM, Reynaud D, Kang YA, Carlin D, Calero-Nieto FJ, Leavitt AD, et al. Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions. Cell Stem Cell. 2015;17(1):35–46.PubMedPubMedCentralCrossRef Pietras EM, Reynaud D, Kang YA, Carlin D, Calero-Nieto FJ, Leavitt AD, et al. Functionally distinct subsets of lineage-biased multipotent progenitors control blood production in normal and regenerative conditions. Cell Stem Cell. 2015;17(1):35–46.PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Cabezas-Wallscheid N, Klimmeck D, Hansson J, Lipka DB, Reyes A, Wang Q, et al. Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis. Cell Stem Cell. 2014;15(4):507–22.PubMedCrossRef Cabezas-Wallscheid N, Klimmeck D, Hansson J, Lipka DB, Reyes A, Wang Q, et al. Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis. Cell Stem Cell. 2014;15(4):507–22.PubMedCrossRef
30.
Zurück zum Zitat Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, et al. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy. Cancer Treat Rev. 2018;63:40–7.PubMedCrossRef Tokunaga R, Zhang W, Naseem M, Puccini A, Berger MD, Soni S, et al. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy. Cancer Treat Rev. 2018;63:40–7.PubMedCrossRef
31.
Zurück zum Zitat Kittang AO, Hatfield K, Sand K, Reikvam H, Bruserud Ø. The chemokine network in acute myelogenous leukemia: molecular mechanisms involved in leukemogenesis and therapeutic implications. Curr Top Microbiol Immunol. 2010;341:149–72.PubMed Kittang AO, Hatfield K, Sand K, Reikvam H, Bruserud Ø. The chemokine network in acute myelogenous leukemia: molecular mechanisms involved in leukemogenesis and therapeutic implications. Curr Top Microbiol Immunol. 2010;341:149–72.PubMed
32.
Zurück zum Zitat Ghosn EE, Cassado AA, Govoni GR, Fukuhara T, Yang Y, Monack DM, et al. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc Natl Acad Sci U S A. 2010;107(6):2568–73.PubMedPubMedCentralCrossRef Ghosn EE, Cassado AA, Govoni GR, Fukuhara T, Yang Y, Monack DM, et al. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc Natl Acad Sci U S A. 2010;107(6):2568–73.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat El Chartouni C, Schwarzfischer L, Rehli M. Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming. Immunobiology. 2010;215(9–10):821–5.PubMedCrossRef El Chartouni C, Schwarzfischer L, Rehli M. Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming. Immunobiology. 2010;215(9–10):821–5.PubMedCrossRef
35.
Zurück zum Zitat Koo C-Y, Giacomini C, Reyes-Corral M, Olmos Y, Tavares IA, Marson CM, et al. Targeting TAO Kinases using a new inhibitor compound delays mitosis and induces mitotic cell death in centrosome amplified breast cancer cells. Mol Cancer Ther. 2017;16(11):2410–21.PubMedCrossRef Koo C-Y, Giacomini C, Reyes-Corral M, Olmos Y, Tavares IA, Marson CM, et al. Targeting TAO Kinases using a new inhibitor compound delays mitosis and induces mitotic cell death in centrosome amplified breast cancer cells. Mol Cancer Ther. 2017;16(11):2410–21.PubMedCrossRef
36.
Zurück zum Zitat Herbst S, Schaible UE, Schneider BE. Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS ONE. 2011;6(5):e19105.PubMedPubMedCentralCrossRef Herbst S, Schaible UE, Schneider BE. Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS ONE. 2011;6(5):e19105.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Rasa SMM, Annunziata F, Krepelova A, Nunna S, Omrani O, Gebert N, et al. Inflammaging is driven by upregulation of innate immune receptors and systemic interferon signaling and is ameliorated by dietary restriction. Cell Rep. 2022;39(13):111017.PubMedCrossRef Rasa SMM, Annunziata F, Krepelova A, Nunna S, Omrani O, Gebert N, et al. Inflammaging is driven by upregulation of innate immune receptors and systemic interferon signaling and is ameliorated by dietary restriction. Cell Rep. 2022;39(13):111017.PubMedCrossRef
38.
Zurück zum Zitat Lu RJ, Wang EK, Benayoun BA. Functional genomics of inflamm-aging and immunosenescence. Brief Funct Genomics. 2022;21(1):43–55.PubMedCrossRef Lu RJ, Wang EK, Benayoun BA. Functional genomics of inflamm-aging and immunosenescence. Brief Funct Genomics. 2022;21(1):43–55.PubMedCrossRef
39.
Zurück zum Zitat Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, et al. The Role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int J Mol Sci. 2021;22(5):2719.PubMedPubMedCentralCrossRef Jang DI, Lee AH, Shin HY, Song HR, Park JH, Kang TB, et al. The Role of tumor necrosis factor alpha (TNF-α) in autoimmune disease and current TNF-α inhibitors in therapeutics. Int J Mol Sci. 2021;22(5):2719.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Wang YF, Wei W, Tangtanatakul P, Zheng L, Lei Y, Lin Z, et al. Identification of shared and asian-specific loci for systemic lupus erythematosus and evidence for roles of type III interferon signaling and lysosomal function in the disease: a multi-ancestral genome-wide association study. Arthritis Rheumatol. 2022;74(5):840–8.PubMedCrossRef Wang YF, Wei W, Tangtanatakul P, Zheng L, Lei Y, Lin Z, et al. Identification of shared and asian-specific loci for systemic lupus erythematosus and evidence for roles of type III interferon signaling and lysosomal function in the disease: a multi-ancestral genome-wide association study. Arthritis Rheumatol. 2022;74(5):840–8.PubMedCrossRef
41.
Zurück zum Zitat Yesilkanal AE, Yang D, Valdespino A, Tiwari P, Sabino AU, Nguyen LC, et al. Limited inhibition of multiple nodes in a driver network blocks metastasis. Elife. 2021;10:e59696.PubMedPubMedCentralCrossRef Yesilkanal AE, Yang D, Valdespino A, Tiwari P, Sabino AU, Nguyen LC, et al. Limited inhibition of multiple nodes in a driver network blocks metastasis. Elife. 2021;10:e59696.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Bian Y, Teper Y, Mathews Griner LA, Aiken TJ, Shukla V, Guha R, et al. Target deconvolution of a multikinase inhibitor with antimetastatic properties identifies TAOK3 as a key contributor to a cancer stem cell-like phenotype. Mol Cancer Ther. 2019;18(11):2097–110.PubMedPubMedCentralCrossRef Bian Y, Teper Y, Mathews Griner LA, Aiken TJ, Shukla V, Guha R, et al. Target deconvolution of a multikinase inhibitor with antimetastatic properties identifies TAOK3 as a key contributor to a cancer stem cell-like phenotype. Mol Cancer Ther. 2019;18(11):2097–110.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Lai T-C, Fang C-Y, Jan Y-H, Hsieh H-L, Yang Y-F, Liu C-Y, et al. Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway. Cell Commun Signal. 2020;18(1):164.PubMedPubMedCentralCrossRef Lai T-C, Fang C-Y, Jan Y-H, Hsieh H-L, Yang Y-F, Liu C-Y, et al. Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway. Cell Commun Signal. 2020;18(1):164.PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Li Z, Oh H, Cung M, Marquez SJ, Sun J, Hammad H, et al. TAOK3 is a MAP3K contributing to osteoblast differentiation and skeletal mineralization. Biochem Biophys Res Commun. 2020;531(4):497–502.PubMedPubMedCentralCrossRef Li Z, Oh H, Cung M, Marquez SJ, Sun J, Hammad H, et al. TAOK3 is a MAP3K contributing to osteoblast differentiation and skeletal mineralization. Biochem Biophys Res Commun. 2020;531(4):497–502.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Wang T, He C. TNF-α and IL-6: the link between immune and bone system. Curr Drug Targets. 2020;21(3):213–27.PubMed Wang T, He C. TNF-α and IL-6: the link between immune and bone system. Curr Drug Targets. 2020;21(3):213–27.PubMed
46.
Zurück zum Zitat Monsalve E, Ruiz-García A, Baladrón V, Ruiz-Hidalgo MJ, Sánchez-Solana B, Rivero S, et al. Notch1 upregulates LPS-induced macrophage activation by increasing NF-kappaB activity. Eur J Immunol. 2009;39(9):2556–70.PubMedCrossRef Monsalve E, Ruiz-García A, Baladrón V, Ruiz-Hidalgo MJ, Sánchez-Solana B, Rivero S, et al. Notch1 upregulates LPS-induced macrophage activation by increasing NF-kappaB activity. Eur J Immunol. 2009;39(9):2556–70.PubMedCrossRef
47.
Zurück zum Zitat Fukuda D, Aikawa E, Swirski FK, Novobrantseva TI, Kotelianski V, Gorgun CZ, et al. Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders. Proc Natl Acad Sci U S A. 2012;109(27):E1868–77.PubMedPubMedCentralCrossRef Fukuda D, Aikawa E, Swirski FK, Novobrantseva TI, Kotelianski V, Gorgun CZ, et al. Notch ligand delta-like 4 blockade attenuates atherosclerosis and metabolic disorders. Proc Natl Acad Sci U S A. 2012;109(27):E1868–77.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Zhang Z, Tang Z, Ma X, Sun K, Fan L, Fang J, et al. TAOK1 negatively regulates IL-17-mediated signaling and inflammation. Cell Mol Immunol. 2018;15(8):794–802.PubMedPubMedCentralCrossRef Zhang Z, Tang Z, Ma X, Sun K, Fan L, Fang J, et al. TAOK1 negatively regulates IL-17-mediated signaling and inflammation. Cell Mol Immunol. 2018;15(8):794–802.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Lee IY, Lim JM, Cho H, Kim E, Kim Y, Oh H-K, et al. MST1 negatively regulates TNFα-Induced NF-κB signaling through modulating LUBAC activity. Mol Cell. 2019;73(6):1138-49.e6.PubMedCrossRef Lee IY, Lim JM, Cho H, Kim E, Kim Y, Oh H-K, et al. MST1 negatively regulates TNFα-Induced NF-κB signaling through modulating LUBAC activity. Mol Cell. 2019;73(6):1138-49.e6.PubMedCrossRef
50.
Zurück zum Zitat Yoneda T, Imaizumi K, Oono K, Yui D, Gomi F, Katayama T, et al. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem. 2001;276(17):13935–40.PubMedCrossRef Yoneda T, Imaizumi K, Oono K, Yui D, Gomi F, Katayama T, et al. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem. 2001;276(17):13935–40.PubMedCrossRef
51.
Zurück zum Zitat Souyris M, Cenac C, Azar P, Daviaud D, Canivet A, Grunenwald S, et al. TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol. 2018;3(19):eaap8855.PubMedCrossRef Souyris M, Cenac C, Azar P, Daviaud D, Canivet A, Grunenwald S, et al. TLR7 escapes X chromosome inactivation in immune cells. Sci Immunol. 2018;3(19):eaap8855.PubMedCrossRef
53.
Zurück zum Zitat Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature. 2011;474(7351):337–42.PubMedPubMedCentralCrossRef Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature. 2011;474(7351):337–42.PubMedPubMedCentralCrossRef
Metadaten
Titel
TAOK3 limits age-associated inflammation by negatively modulating macrophage differentiation and their production of TNFα
verfasst von
Alexandre Poirier
Chenyue Wu
Ana Maria Hincapie
Zuzet Martinez-Cordova
Belma Melda Abidin
Michel L. Tremblay
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
Immunity & Ageing / Ausgabe 1/2023
Elektronische ISSN: 1742-4933
DOI
https://doi.org/10.1186/s12979-023-00350-y

Weitere Artikel der Ausgabe 1/2023

Immunity & Ageing 1/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.